Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × Imlunestrant × Clear all

NCT04975308 2025-07-11

EMBER-3

Phase 3 Active not recruiting

874 enrolled 29 charts 1 FDA

Breast Neoplasms, Neoplasm Metastasis